CLINICAL ROLE -
Treatment Advances Spur Steady Decline in Cancer Deaths
Nearly 2 million cancer deaths have been avoided over last 25 years.
Read More
HIV Drug Access Limited for Patients in Exchange Plans
Study finds many silver plans have higher out-of-pocket costs for most the commonly prescribed HIV treatments.
National Health Care Spending Growth Slows Under ACA
CMS report shows spending rates are lower compared with the years prior to health care reform.
Cancer Treatment Advances Highlight Specialty Pharmacy Week in Review
Top articles of the week on Specialty Pharmacy Times.
High Dose Vitamin D May Benefit Multiple Sclerosis Patients
Vitamin D3 found to aid immune response regulation among patients with MS.
Women in States with Medicaid Expansion More Likely to Have Mammography
Study finds adoption of Medicaid expansion could reduce disparities in breast cancer screening.
Optimizing Relationships Among Manufacturers and Providers
David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses methods to improve communication among drug manufacturers and health care providers.
Treating Hepatitis C in Prison Population Could Limit Spread
Targeted intervention programs could offer significant benefits in HCV prevention.
Novel Targeted Therapy May Eliminate HIV
Alpha therapy shows promise in selectively killing infected cells from the central nervous system.
Combination of Immunotherapy with Antibody Drug Offers Hope in Breast Cancer Treatment
Research may lead to new treatment approach for cancer.
How Can Technology Improve Clinical Support for Specialty Pharmacy Patients?
Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC discusses the use of technology to optimize clinical services in specialty pharmacy.
Drug Combination Shows Promise in Advanced Prostate Cancer
Combination of treatments may slow disease progression.
2015: The Year in Hepatitis C News
Most read HCV articles of the year.
2015: The Year in HIV News
Most read HIV articles from the past year.
2015: The Year in Multiple Sclerosis News
Most read multiple sclerosis articles from the past year.
2015: Best of Specialty Pharmacy Times Journal
Catch up with the most popular articles from the print journal of Specialty Pharmacy Times this year.
Truvada Use as Needed May Prevent HIV Transmission
Taking drug around periods of sexual activity lowers transmission rates.
Ten Most Read Articles on Specialty Pharmacy Times in 2015
Catch up with the most popular articles from the last year.
Advanced Melanoma Immunotherapy May Change Treatment of Disease
Keytruda acts by allowing T cells to recognize and attack cancer cells.
Natural Killer Cells Show Promise in Treating Multiple Myeloma
Early trial shows potential of stem cell transplant combined and high-dose chemotherapy.
Top Ten Most Read Articles on Specialty Pharmacy Times in December
Catch up with any news you may have missed this month.
Switching Kinase Inhibitors Shows Favorable Outcomes in Leukemia Therapy
Researchers explore alternate treatment for chronic lymphocytic leukemia.
Stem Cell Transplant Not Found to Improve Crohn's Disease
Significant improvement in sustained disease remission following transplantation not observed.
Breakthrough Cancer Drug Highlights Week in Specialty Pharmacy
Top stories of the week on Specialty Pharmacy Times.
New Therapies Projected to Drive Acute Myeloid Leukemia Treatment Market Growth
Global AML market forecast to reach nearly a billion dollars by 2024.
Leukemia Drug Superior to Traditional Chemotherapy
Ibrutinib is significantly more effective than chlorambucil in chronic lymphocytic leukemia.
Overcoming Specialty Pharmacy Reporting Demands
Joseph Morse, president and chief operating officer of Therigy, LLC, discusses how specialty pharmacies can meet the reporting requirements required by manufacturers and payers.
Lung Cancer Drug Gets Breakthrough Therapy Designation
Experimental tyrosine kinase inhibitor targets T790M mutation-positive non-small cell lung cancer.